Extensive review of seroprevalence provides a global panorama on immunity

CITF-funded SeroTracker carried out a living systematic review of 968 seroprevalence studies that included 9.3 million participants in 74 countries. Their findings, published in PLOS One, suggest that the general population median seroprevalence worldwide was low (4.5%), but found important differences when comparing infection rates from diagnostic testing.   In this systematic review and … Continue reading Extensive review of seroprevalence provides a global panorama on immunity